NCT06297577View on ClinicalTrials.gov

Clinical Evaluation of Injectable Alb-PRF in the Management of Intrabony Defect in Stage-III Periodontitis Patients

NANot yet recruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 30, 2024

Primary Completion Date

August 30, 2025

Study Completion Date

October 30, 2025

Conditions
Intrabony Periodontal Defect
Interventions
PROCEDURE

Albumin Platelet Rich Fibrin (Alb-PRF) combined with minimally invasive surgical technique (MIST)

Albumin-PRF will be placed into intrabony defect

PROCEDURE

Minimally invasive surgical technique (MIST)

MIST will be the surgical access for treatment of Intrabony defect

All Listed Sponsors
lead

Cairo University

OTHER

NCT06297577 - Clinical Evaluation of Injectable Alb-PRF in the Management of Intrabony Defect in Stage-III Periodontitis Patients | Biotech Hunter | Biotech Hunter